MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Loneliness accelerates parkinsonism decline in parkinsonian community-dwelling older adults

D. Gonzalez, M. Wilson, M. Tosin, M. Roy, C. Goetz (Chicago, USA)

Meeting: 2025 International Congress

Keywords: Parkinsonism

Category: Parkinsonism (Other)

Objective: To determine the longitudinal impact of loneliness on parkinsonism, relative to the longitudinal impact of parkinsonism on loneliness, in parkinsonian adults.

Background: The link between loneliness and parkinsonism has been demonstrated, both in community-based samples and in those with Parkinson’s disease (PD). The majority of these studies have demonstrated this link cross-sectionally, thus it is unclear which of the two has more longitudinal import.

Method: We selected individuals from several Rush Alzheimer’s Disease Center cohorts who had completed parkinsonism (modified Unified Parkinson’s Disease Rating Scale, Part III) and loneliness (brief de Jong Gierveld Loneliness Scale) ratings, alongside two or more key parkinsonism features and two or more follow-ups within a 15-year period. Participant-grouped multilevel models alternated loneliness-parkinsonism as outcome-predictor, and included time, time-predictor interaction, and demographics as covariates.

Results: 1,700 individuals (75.6% female, Mage=80.4, Meducation=14.8 years; 64.9% White) were included and followed over 5.3 years on average. In the loneliness model, parkinsonism (B=.08) and time (B=.15), but not time×parkinsonism (B=.03), were significant predictors (conditional-R2=.61, marginal-R2=.07). In the parkinsonism model, loneliness (B=.07), time (B=.25), and time×loneliness (B=.11) were significant predictors (conditional-R2=.61, marginal-R2=.13).

Conclusion: The loneliness→parkinsonism model had greater fixed-effect variance explained, and both time, and time×loneliness had greater predictive power, relative to the parkinsonism→loneliness model. In sum, although the relationship is bidirectional, loneliness has more prospective weight in preceding more severe parkinsonism with steeper rate of decline.

Table 1

Table 1

References: González DA, Tosin MH de S, Goetz CG. The plight of loneliness in Parkinson’s disease: New opportunities. Parkinsonism Relat Disord. 2022;105:145-148. doi:10.1016/j.parkreldis.2022.10.029

To cite this abstract in AMA style:

D. Gonzalez, M. Wilson, M. Tosin, M. Roy, C. Goetz. Loneliness accelerates parkinsonism decline in parkinsonian community-dwelling older adults [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/loneliness-accelerates-parkinsonism-decline-in-parkinsonian-community-dwelling-older-adults/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/loneliness-accelerates-parkinsonism-decline-in-parkinsonian-community-dwelling-older-adults/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley